Use Of Sahajan

डाबर सितोपलादि चूर्ण सर्दी-खांसी की आयुर्वेदिक औषधि है. यह पिप्पली जैसे औषधीय पौधों से बनाया जाता है, जो आयुर्वेद के शास्त्रों के हिसाब से प्रकृति में उपलब्ध सर्वोत्तम एक्सपेक्टोरेंट (expectorants) में से एक है. डाबर सितोपलादि चूर्ण 100% प्राकृतिक अवयवों से बना है जो खांसी और सर्दी के खिलाफ काम करते हैं और आपको उसकी तकलीफ से छुटकारा दिलाता है.इसके एंटीऑक्सीडेंट और एंटी-इंफ्लेमेटरी गुणों के कारण यह मधुमेह, एनीमिया और माइग्रेन के इलाज में भी मदद करता है। यह सभी आयु समूहों के लिए उपयुक्त एक सुरक्षित और खांसी रोकने वाली प्राकृतिक औषधि है. डाबर सितोपलादि चूर्ण के फायदे - Dabur Sitopaladi Churna Benefits in Hindi खांसी,सर्दी  और जुकाम में फायदेमंद.  पिप्पली में औषधीय गुणों से भरपूर और खांसी की समस्या से छुटकारा मिलता है. पिप्पली शरीर में आसानी से अवशोषित हो जाती है और शरीर को पोषण और ऊर्जा प्रदान करती है. हाथ - पैरों में जलन और भूख न लगने की समस्या से भी राहत दिलाता है. डाबर सितोपलादि चूर्ण की खुराक - Dabur Sitopaladi Churna Dosage in Hindi  आधा से 1 चम्मच (3-6 ग्राम) दिन में दो बार शहद के साथ या आयुर्वेद चिकित्सक के निर्देशानुसार सेवन करें। यह भी पढ़े ► डाबर शिलाजीत गोल्ड के फायदे डाबर सितोपलादि चूर्ण का संग्रहण और सुरक्षा जानकारी - Dabur Sitopaladi Churna Storage and Safety Information in Hindi  निर्धारित  खुराक से अधिक न ले  उपयोग करने से पहले लेबल को ध्यान से पढ़ें। इसे बच्चों की पहुंच से दूर रखें। शीतल एवं सूखी जगह पर भंडारित करें। डाबर सितोपलादि चूर्ण के घटक तत्व - Dabur Sitopaladi Churna Ingredients in Hindi  डाबर सितोपलादि चूर्ण में मिश्री, वंशलोचन, पिप्पली, इला और त्वक प्रमुख सामग्री के रूप में शामिल हैं।  डाबर सितोपलादि चूर्ण की ऑनलाइन खरीद  - Dabur Sitopaladi Churna Buy Online  डाबर सितोपलादि चूर्ण ► Dabur Sitopaladi Churna डाबर सितोपलादि चूर्ण की उपलब्धता - Dabur Sitopaladi Churna Availability in Hindi डाबर सितोपलादि चूर्ण / पाउडर 30 ग्राम, 60 ग्राम, 100 ग्राम और 500 ग्राम के पैकेट में उपलब्ध है.  डाबर सितोपलादि चूर्ण से संबंधित प्रश्न - Dabur Sitopaladi Churna FAQs in Hindi  क्या सितोपलादि चूर्ण की आदत पड़ जाती है? ►नहीं, ऐसा बिलकुल नहीं होता. लेकिन चिकित्सकीय देखरेख में लेना श्रेयस्कर होगा.  क्या सितोपलादि चूर्ण खाने के बाद नींद आती है? ►नहीं. निर्धारित मात्रा में खुराक लेने से ऐसी कोई समस्या नहीं आती. लेकिन यदि आपको ऐसा लग रहा है तो चिकित्सक से संपर्क करे.  क्या सितोपलादि चूर्ण खांसी से राहत दिलाने में मदद करता है? ►हाँ. सितोपलादि चूर्ण को 2-4 ग्राम की मात्रा में दिन में दो बार लेने से खांसी से छुटकारा मिलता है. यह भी पढ़े ► सितोपलादि चूर्ण के फायदे और नुकसान किसी भी प्रकार की दवाई लेने से पहले डॉक्टर से सलाह लेना आवश्यक है। आयुर्वेद के अनुभवी डॉक्टर से निशुल्क: परामर्श लें @ +91-9205773222

Colombo, July 17 (IANS) Sri Lanka's National Medicines Regulatory Authority (NMRA) has approved the Chinese Sinovac Covid-19 vaccine for emergency use in the island nation.Accordingly, all Covid-19 vaccines approved by the World Health Organisation (WHO) can now be used in Sri Lanka, State Minister of Production, Supply and Regulation of Pharmaceuticals Channa Jayasumana said on Friday.To date, Sri Lanka has administered over 4 million first doses of the coronavirus vaccines across the country, with the majority having received the Sinopharm vaccines.Thirty six per cent of the population above the age of 30 years in Sri Lanka have been administered with at least one dose of a Covid-19 vaccine, Health Promotion Bureau (HPB) Director Ranjith Batuwanthudawa said on Thursday.In capital Colombo, one of the worst affected by the virus, 70 per cent of the target population have received the first dose of the vaccine, while 25 per cent have received both doses, Batuwanthudawa said.Last week, President Gotabaya Rajapaksa had put forward a comprehensive mechanism for vaccinating a majority of the Sri Lankan population before September.Rajapaksa said the amount of coronavirus vaccines scheduled to be received in July will be made available to the public, and the districts identified as high-risk areas for spreading the coronavirus will be given priority in vaccine distribution.Sri Lanka is presently under the a third wave of the pandemic with authorities warning of a further spread of the Delta variant.The country has to date recorded 282,060 confirmed coronavirus cases, while 3,702 deaths have been reported.--IANSksk/

Hyderabad, July 15 (IANS) Scientists at the Indian Institute of Technology Hyderabad (IITH) have developed COVIHOME, an artificial intelligence-powered Covid-19 test that allows self-testing at home.On obtaining ICMR approvals, and after commercialisation, the kit developed by Prof Shiv Govind Singh, Department of Electrical Engineering, will be available in the market at an affordable price.This test kit can produce results within 30 minutes for both symptomatic and asymptomatic patients. The major benefit of this testing kit is that it does not require RT-PCR (Reverse Transcription Polymerase Chain Reaction), an expert human resource, and a BSL 2 lab facility for the extraction of RNA, so it has potential for one to take the test at home without expert supervision.Explaining the benefits of the testing kit, Shiv Govind Singh said, "A major objective of the research team for the development of the COVIHOME Test Kit was to break the transmission chain through affordable testing. We have already filed a patent for the device and are now looking for industry partners for ToT of technology for mass production".As per IITH, CSIR-CCMB has performed the validation of the rapid RNA electronic diagnostic device for detection ofSARS-Cov-2 virus in the swab samples independently with the in-house samples and hospital samples as advised by ICMR. These samples were confirmed for their positivity or negativity by the RT-PCR method.The validation report confirmed the kit's efficiency at 94.2 percent, Sensitivity 91.3 percent and Specificity 98.2 percent.While a test currently costs around Rs 400, the developers say that mass production of the testing kit will help to reduce the cost to around Rs 300 per test.Speaking about the role of IIT Hyderabad in helping tackle the COVID-19 pandemic, Prof B S Murty, Director, IIT Hyderabad, said, "IITH has come up with many unique & novel socio-technological initiatives and delivered remarkable results during this pandemic. Prof Shiv Govind's "COVIHOME" is one such admirable milestone. I am confident it will play a significant role in the safe & fast diagnosis of COVID-19 and minimize its spread".The COVIHOME testing kit was developed by the research team of Dr Suryasnata Tripathy, Supraja Patta, Swati Mohanty, and other students led by Shiv Govind Singh, Department of Electrical Engineering.The initial clinical trial and testing of the device was performed at ESIC Medical College and Hospital in Hyderabad. "Dean ESIC, Prof Srinivas M, and his team Dr Imaran, Dr Swati, and Dr Rajeev have played a big role in the successful development of this novel kit", said Singh.--IANSpvn/bg

Havana, July 10 (IANS) The Cuban Centre for State Control of Medicines, Equipment and Medical Devices has approved the emergency use authorisation to Abdala, one of five domestic vaccines against Covid-19.The regulatory body said in a statement on Friday that it granted the emergency use authorization to Abdala "once it was confirmed that the requirements and parameters demanded in terms of quality, safety and efficacy were met", Xinhua news agency reported.According to Cuban scientists, the vaccine developed by the Center for Genetic Engineering and Biotechnology (CIGB) has an efficacy rate of 92.28 per cent in three doses administered at 14-day intervals.The decision makes Abdala the first vaccine made in Latin America that meets the requirements for large-scale use in the country and even for export.According to the latest data from the Cuban Ministry of Health, more than 7 million doses of domestic vaccines have been administered, and just over 3 million people have received at least one dose as participants in clinical trials or in emergency intervention.Cuba on Friday saw its worst pandemic figures since the start of the outbreak 16 months ago.With 6,422 new cases and 28 more fatalities, the overall infection tally and death toll increased to 224,818 and 1,459.--IANSksk/